BioSpace News Archive

Press Releases

Savara Receives Refusal to File (RTF) Letter From the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for MOLBREEVI* to Treat Patients With Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP)

May 27, 2025
·
6 min read
Press Releases

Incyte to Present at Upcoming Investor Conference on Monday, June 9, 2025 at 11:20 am (ET)

May 27, 2025
·
1 min read
Press Releases

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

May 27, 2025
·
3 min read
Press Releases

Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis

May 27, 2025
·
5 min read
Press Releases

AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders

May 27, 2025
·
11 min read
Press Releases

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

May 27, 2025
·
5 min read
Press Releases

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

May 27, 2025
·
6 min read
Press Releases

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)

May 27, 2025
·
6 min read
Press Releases

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

May 27, 2025
·
2 min read
Press Releases

PreveCeutical Welcomes Stephen Glover as Corporate Advisor

May 27, 2025
·
6 min read